Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases

Clinical trial NCT03939533 · COMPLETED

Trial details

NCT number: NCT03939533
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency Disorder

Start date: 2019-10-17
Primary completion: 2022-01-03
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.